Related Experiment Video
Updated: Mar 25, 2026

Multiplexed Fluorescent Immunohistochemical Staining of Four Endometrial Immune Cell Types in Recurrent Miscarriage
Published on: August 4, 2021
Relationship between TLR4 and CCL2 expression and recurrent spontaneous abortion.
1Department of Gynecology and Obstetrics, Qilu Hospital, Shandong University, Jinan, China.
Recurrent spontaneous abortion (RSA) is linked to higher levels of Toll-like receptor 4 (TLR4) and chemokine (C-C motif) ligand 2 (CCL2). Measuring these immune factors in blood may help monitor RSA risk in pregnant women.
Area of Science:
- Immunology
- Reproductive Medicine
- Biomarker Discovery
Background:
- Recurrent spontaneous abortion (RSA) significantly impacts women's reproductive health.
- Immune system dysregulation is increasingly implicated in pregnancy complications like RSA.
- Toll-like receptor 4 (TLR4) and chemokine (C-C motif) ligand 2 (CCL2) are associated with various pregnancy disorders.
Purpose of the Study:
- To investigate the correlation between TLR4 and CCL2 levels and the occurrence of RSA.
- To evaluate the potential of TLR4 and CCL2 as diagnostic markers for RSA.
- To quantify and compare TLR4 and CCL2 expression in RSA patients versus healthy controls.
Main Methods:
- A case-control study involving 36 RSA patients and 36 healthy controls.
- Collection of decidual, chorionic tissues, and venous blood samples.
- Quantification of TLR4 and CCL2 using fluorescent quantitative-polymerase chain reaction (mRNA) and enzyme-linked immunosorbent assay (serum levels).
Main Results:
- Significantly elevated mRNA levels of TLR4 and CCL2 were observed in RSA patients compared to controls (P < 0.05).
- Serum levels of both TLR4 and CCL2 were also significantly higher in the RSA group (P < 0.05).
- A positive correlation was found between serum concentrations and tissue mRNA expression of TLR4 and CCL2.
Conclusions:
- Both TLR4 and CCL2 are closely associated with the pathogenesis of recurrent spontaneous abortion.
- Serum levels of TLR4 and CCL2 show promise as potential biomarkers for monitoring RSA in pregnant women.
More Related Videos
06:56A Flow Cytometry-based Assay to Identify Compounds That Disrupt Binding of Fluorescently-labeled CXC Chemokine Ligand 12 to CXC Chemokine Receptor 4
Published on: March 10, 2018
07:46Author Spotlight: Advancing Reproductive Immunology with a Protocol for the Quantitative Evaluation of Endometrial Immune Cells
Published on: October 13, 2023